摘要
目的探究尼莫地平联合阿司匹林治疗脑血管痉挛性头痛头晕的效果及安全性。方法106例脑血管痉挛性头痛头晕患者,根据数字表随机法分为对照组和研究组,每组53例。对照组应用尼莫地平片治疗,研究组采用尼莫地平+阿司匹林治疗。比较两组临床疗效及不良反应发生情况。结果研究组治疗总有效率94.34%高于对照组的81.13%,差异具有统计学意义(P<0.05)。研究组不良反应发生率5.66%与对照组的3.77%比较,差异无统计学意义(P>0.05);两组出现轻微腹部不适未经特殊处理,自行缓解。结论尼莫地平+阿司匹林治疗脑血管痉挛性头痛头晕患者,疗效显著,不良反应少,安全可靠,值得临床推广。
Objective To investigate the effect and safety of nimodipine combined with aspirin in the treatment of cerebral vasospastic headache and dizziness.Methods A total of 106 patients with were divided into control and research groups according to the random numerical table,with 53 cases in each group.The control group was treated with nimodipine tablets,and the research group was treated with nimodipine and aspirin.The clinical efficacy and occurrence of adverse reactions were compared between the two groups.Results The total effective rate of treatment 94.34%in the research group was higher than 81.13%in the control group,and the difference was statistically significant(P<0.05).The incidence of adverse reactions in the research group was 5.66%,which was not statistically significant compared with 3.77%in the control group(P>0.05).Both groups had slight abdominal discomfort,which relieved spontaneously without special treatment.Conclusion Combination of nimodipine and aspirin has significant effect in the treatment of patients with cerebral vasospasm headache and dizziness,with less adverse reactions.It is safe and reliable,and is worthy of wide clinical promotion.
作者
穆兰师
MU Lan-shi(Department of Neurology,Jinzhou Central Hospital,Jinzhou 121001,China)
出处
《中国实用医药》
2022年第8期175-177,共3页
China Practical Medicine
